Hydrochlorothiazide W/ Reserpine

   
Google
 
Web NewDrugInformation.com

Hydrochlorothiazide W/ Reserpine


Drug - Hydrochlorothiazide W/ Reserpine
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Hydrochlorothiazide; Reserpine
Multiple ingredients are in alphabetical order.

Strength - 50MG;0.125MG
The potency of the active ingredient(s), Hydrochlorothiazide; Reserpine. May repeat for multiple part products.

Applicant - WATSON LABS
The firm name holding legal responsibility for Hydrochlorothiazide W/ Reserpine. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 084467
The FDA assigned number to Hydrochlorothiazide W/ Reserpine. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Hydrochlorothiazide W/ Reserpine. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Hydrochlorothiazide W/ Reserpine was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Hydrochlorothiazide W/ Reserpine. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Hydrochlorothiazide W/ Reserpine is in. Format is RX, OTC, DISCN.

Applicant Full Name - Watson Laboratories Inc
The full name of the firm holding legal responsibility for the new application of Hydrochlorothiazide W/ Reserpine.

Hydrochlorothiazide W/ Reserpine